APO Research
Talk to an analyst

APO RESEARCH · REPORT

Furosemide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Furosemide Industry Growth and Trends Forecast to 2032

20 December 202593 pages

Choose your research edition.

Industry ResearchFurosemide Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Furosemide Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Furosemide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Furosemide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Furosemide Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Furosemide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Furosemide include Sun Pharm Inds, Sandoz, Sanofi Aventis, Mylan, West-Ward Pharms, US Pharm Holdings, Ivax Sub Teva Pharms, Hospira and Emcure Pharms, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Furosemide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Furosemide market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Furosemide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Furosemide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Furosemide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Furosemide Market by Company

Sun Pharm Inds

Sandoz

Sanofi Aventis

Mylan

West-Ward Pharms

US Pharm Holdings

Ivax Sub Teva Pharms

Hospira

Emcure Pharms

Furosemide Segment by Type

Injection

Solution

Tablet

Furosemide Segment by Application

Clinics

Hospital

Pharmacy

Others

Furosemide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furosemide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Furosemide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furosemide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Furosemide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Furosemide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Solution Table 3. Major Company of Tablet Table 4. Global Furosemide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Furosemide Sales by Type (2021-2026) & (tons) Table 6. Global Furosemide Sales Market Share in Volume by Type (2021-2026) Table 7. Global Furosemide Sales by Type (2021-2026) & (US$ Million) Table 8. Global Furosemide Sales Market Share in Value by Type (2021-2026) Table 9. Global Furosemide Price by Type (2021-2026) & (US$/kg) Table 10. Global Furosemide Sales by Type (2027-2032) & (tons) Table 11. Global Furosemide Sales Market Share in Volume by Type (2027-2032) Table 12. Global Furosemide Sales by Type (2027-2032) & (US$ Million) Table 13. Global Furosemide Sales Market Share in Value by Type (2027-2032) Table 14. Global Furosemide Price by Type (2027-2032) & (US$/kg) Table 15. North America Furosemide Sales by Type (2021-2026) & (tons) Table 16. North America Furosemide Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Furosemide Sales by Type (2021-2026) & (tons) Table 18. Europe Furosemide Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Furosemide Sales by Type (2021-2026) & (tons) Table 20. Asia-Pacific Furosemide Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Furosemide Sales by Type (2021-2026) & (tons) Table 22. Latin America Furosemide Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Furosemide Sales by Type (2021-2026) & (tons) Table 24. Middle East and Africa Furosemide Sales by Type (2021-2026) & (US$ Million) Table 25. Furosemide Industry Trends Table 26. Furosemide Industry Drivers Table 27. Furosemide Industry Opportunities and Challenges Table 28. Furosemide Industry Restraints Table 29. Global Furosemide Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Furosemide Revenue Market Share by Company (2021-2026) Table 31. Global Furosemide Sales by Company (2021-2026) & (tons) Table 32. Global Furosemide Sales Share by Company (2021-2026) Table 33. Global Furosemide Market Price by Company (2021-2026) & (US$/kg) Table 34. Global Furosemide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Furosemide Major Company Production Sites and Headquarters Table 36. Global Furosemide Company, Product Type & Application Table 37. Global Furosemide Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Furosemide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Furosemide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Furosemide Sales by Region (2021-2026) & (tons) Table 42. Global Furosemide Sales Market Share in Volume by Region (2021-2026) Table 43. Global Furosemide Sales by Region (2021-2026) & (US$ Million) Table 44. Global Furosemide Sales Market Share in Value by Region (2021-2026) Table 45. Global Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 46. Global Furosemide Sales by Region (2027-2032) & (tons) Table 47. Global Furosemide Sales Market Share in Volume by Region (2027-2032) Table 48. Global Furosemide Sales by Region (2027-2032) & (US$ Million) Table 49. Global Furosemide Sales Market Share in Value by Region (2027-2032) Table 50. Global Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 51. Global Furosemide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Furosemide Sales by Application (2021-2026) & (tons) Table 53. Global Furosemide Sales Market Share in Volume by Application (2021-2026) Table 54. Global Furosemide Sales by Application (2021-2026) & (US$ Million) Table 55. Global Furosemide Sales Market Share in Value by Application (2021-2026) Table 56. Global Furosemide Price by Application (2021-2026) & (US$/kg) Table 57. Global Furosemide Sales by Application (2027-2032) & (tons) Table 58. Global Furosemide Sales Market Share in Volume by Application (2027-2032) Table 59. Global Furosemide Sales by Application (2027-2032) & (US$ Million) Table 60. Global Furosemide Sales Market Share in Value by Application (2027-2032) Table 61. Global Furosemide Price by Application (2027-2032) & (US$/kg) Table 62. North America Furosemide Sales by Application (2021-2026) & (tons) Table 63. North America Furosemide Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Furosemide Sales by Application (2021-2026) & (tons) Table 65. Europe Furosemide Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Furosemide Sales by Application (2021-2026) & (tons) Table 67. Asia-Pacific Furosemide Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Furosemide Sales by Application (2021-2026) & (tons) Table 69. Latin America Furosemide Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Furosemide Sales by Application (2021-2026) & (tons) Table 71. Middle East and Africa Furosemide Sales by Application (2021-2026) & (US$ Million) Table 72. Sun Pharm Inds Company Information Table 73. Sun Pharm Inds Business Overview Table 74. Sun Pharm Inds Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. Sun Pharm Inds Furosemide Product Portfolio Table 76. Sun Pharm Inds Recent Development Table 77. Sandoz Company Information Table 78. Sandoz Business Overview Table 79. Sandoz Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. Sandoz Furosemide Product Portfolio Table 81. Sandoz Recent Development Table 82. Sanofi Aventis Company Information Table 83. Sanofi Aventis Business Overview Table 84. Sanofi Aventis Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 85. Sanofi Aventis Furosemide Product Portfolio Table 86. Sanofi Aventis Recent Development Table 87. Mylan Company Information Table 88. Mylan Business Overview Table 89. Mylan Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 90. Mylan Furosemide Product Portfolio Table 91. Mylan Recent Development Table 92. West-Ward Pharms Company Information Table 93. West-Ward Pharms Business Overview Table 94. West-Ward Pharms Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 95. West-Ward Pharms Furosemide Product Portfolio Table 96. West-Ward Pharms Recent Development Table 97. US Pharm Holdings Company Information Table 98. US Pharm Holdings Business Overview Table 99. US Pharm Holdings Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 100. US Pharm Holdings Furosemide Product Portfolio Table 101. US Pharm Holdings Recent Development Table 102. Ivax Sub Teva Pharms Company Information Table 103. Ivax Sub Teva Pharms Business Overview Table 104. Ivax Sub Teva Pharms Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 105. Ivax Sub Teva Pharms Furosemide Product Portfolio Table 106. Ivax Sub Teva Pharms Recent Development Table 107. Hospira Company Information Table 108. Hospira Business Overview Table 109. Hospira Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 110. Hospira Furosemide Product Portfolio Table 111. Hospira Recent Development Table 112. Emcure Pharms Company Information Table 113. Emcure Pharms Business Overview Table 114. Emcure Pharms Furosemide Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 115. Emcure Pharms Furosemide Product Portfolio Table 116. Emcure Pharms Recent Development Table 117. North America Furosemide Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 118. North America Furosemide Sales by Country (2021-2026) & (tons) Table 119. North America Furosemide Sales Market Share by Country (2021-2026) Table 120. North America Furosemide Sales Forecast by Country (2027-2032) & (tons) Table 121. North America Furosemide Sales Market Share Forecast by Country (2027-2032) Table 122. North America Furosemide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Furosemide Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Furosemide Market Share by Country (2021-2026) Table 125. North America Furosemide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Furosemide Market Share Forecast by Country (2027-2032) Table 127. Europe Furosemide Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 128. Europe Furosemide Sales by Country (2021-2026) & (tons) Table 129. Europe Furosemide Sales Market Share by Country (2021-2026) Table 130. Europe Furosemide Sales Forecast by Country (2027-2032) & (tons) Table 131. Europe Furosemide Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Furosemide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Furosemide Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Furosemide Market Share by Country (2021-2026) Table 135. Europe Furosemide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Furosemide Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Furosemide Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Furosemide Sales by Country (2021-2026) & (tons) Table 139. Asia-Pacific Furosemide Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Furosemide Sales Forecast by Country (2027-2032) & (tons) Table 141. Asia-Pacific Furosemide Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Furosemide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Furosemide Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Furosemide Market Share by Country (2021-2026) Table 145. Asia-Pacific Furosemide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Furosemide Market Share Forecast by Country (2027-2032) Table 147. Latin America Furosemide Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 148. Latin America Furosemide Sales by Country (2021-2026) & (tons) Table 149. Latin America Furosemide Sales Market Share by Country (2021-2026) Table 150. Latin America Furosemide Sales Forecast by Country (2027-2032) & (tons) Table 151. Latin America Furosemide Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Furosemide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Furosemide Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Furosemide Market Share by Country (2021-2026) Table 155. Latin America Furosemide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Furosemide Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Furosemide Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Furosemide Sales by Country (2021-2026) & (tons) Table 159. Middle East and Africa Furosemide Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Furosemide Sales Forecast by Country (2027-2032) & (tons) Table 161. Middle East and Africa Furosemide Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Furosemide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Furosemide Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Furosemide Market Share by Country (2021-2026) Table 165. Middle East and Africa Furosemide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Furosemide Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Furosemide Distributors List Table 170. Furosemide Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Furosemide Image Figure 2. Global Furosemide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Furosemide Market Size (2021-2032) & (US$ Million) Figure 4. Global Furosemide Sales (2021-2032) & (tons) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (tons) Figure 7. Solution Image Figure 8. Global Solution Sales YoY Growth (2021-2032) & (tons) Figure 9. Tablet Image Figure 10. Global Tablet Sales YoY Growth (2021-2032) & (tons) Figure 11. Global Furosemide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Furosemide Market Share by Type 2025 VS 2032 Figure 13. North America Furosemide Sales Market Share in Volume by Type in 2025 Figure 14. North America Furosemide Sales Market Share in Value by Type in 2025 Figure 15. Europe Furosemide Sales Market Share in Volume by Type in 2025 Figure 16. Europe Furosemide Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Furosemide Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Furosemide Sales Market Share in Value by Type in 2025 Figure 19. Latin America Furosemide Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Furosemide Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Furosemide Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Furosemide Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Furosemide Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (tons) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (tons) Figure 29. Pharmacy Image Figure 30. Global Pharmacy Sales YoY Growth (2021-2032) & (tons) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 33. Global Furosemide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Furosemide Market Share by Application 2025 VS 2032 Figure 35. North America Furosemide Sales Market Share in Volume by Application in 2025 Figure 36. North America Furosemide Sales Market Share in Value by Application in 2025 Figure 37. Europe Furosemide Sales Market Share in Volume by Application in 2025 Figure 38. Europe Furosemide Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Furosemide Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Furosemide Sales Market Share in Value by Application in 2025 Figure 41. Latin America Furosemide Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Furosemide Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Furosemide Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Furosemide Sales Market Share in Value by Application in 2025 Figure 45. North America Furosemide Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. North America Furosemide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Furosemide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Furosemide Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Furosemide Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Europe Furosemide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Furosemide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Furosemide Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Furosemide Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Asia-Pacific Furosemide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Furosemide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Furosemide Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Furosemide Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Latin America Furosemide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Furosemide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Furosemide Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Furosemide Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 62. Middle East and Africa Furosemide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Furosemide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Furosemide Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Furosemide Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Furosemide Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Solution
  • Tablet
Applications
  • Clinics
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Sun Pharm Inds
  • Sandoz
  • Sanofi Aventis
  • Mylan
  • West-Ward Pharms
  • US Pharm Holdings
  • Ivax Sub Teva Pharms
  • Hospira
  • Emcure Pharms

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Furosemide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Furosemide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Furosemide Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Solution
  8. 1.3.3 Tablet
  9. 1.4 Global Furosemide Market Size by Type
  10. 1.4.1 Global Furosemide Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Furosemide Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Furosemide Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Furosemide Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Furosemide Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Furosemide Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Furosemide Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Furosemide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Furosemide Industry Trends
  2. 2.2 Furosemide Industry Drivers
  3. 2.3 Furosemide Industry Opportunities and Challenges
  4. 2.4 Furosemide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Furosemide Revenue (2021-2026)
  2. 3.2 Global Top Players by Furosemide Sales (2021-2026)
  3. 3.3 Global Top Players by Furosemide Price (2021-2026)
  4. 3.4 Global Furosemide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Furosemide Major Company Production Sites & Headquarters
  6. 3.6 Global Furosemide Company, Product Type & Application
  7. 3.7 Global Furosemide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Furosemide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Furosemide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Furosemide Tier 1, Tier 2, and Tier 3
4 Furosemide Regional Status and Outlook
  1. 4.1 Global Furosemide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Furosemide Historic Market Size by Region
  3. 4.2.1 Global Furosemide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Furosemide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Furosemide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Furosemide Forecasted Market Size by Region
  7. 4.3.1 Global Furosemide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Furosemide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Furosemide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Furosemide by Application
  1. 5.1 Furosemide Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Furosemide Market Size by Application
  7. 5.2.1 Global Furosemide Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Furosemide Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Furosemide Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Furosemide Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Furosemide Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Furosemide Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Furosemide Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Furosemide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sun Pharm Inds
  2. 6.1.1 Sun Pharm Inds Company Information
  3. 6.1.2 Sun Pharm Inds Business Overview
  4. 6.1.3 Sun Pharm Inds Furosemide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharm Inds Furosemide Product Portfolio
  6. 6.1.5 Sun Pharm Inds Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Furosemide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Furosemide Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Sanofi Aventis
  14. 6.3.1 Sanofi Aventis Company Information
  15. 6.3.2 Sanofi Aventis Business Overview
  16. 6.3.3 Sanofi Aventis Furosemide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Aventis Furosemide Product Portfolio
  18. 6.3.5 Sanofi Aventis Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Furosemide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Furosemide Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 West-Ward Pharms
  26. 6.5.1 West-Ward Pharms Company Information
  27. 6.5.2 West-Ward Pharms Business Overview
  28. 6.5.3 West-Ward Pharms Furosemide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 West-Ward Pharms Furosemide Product Portfolio
  30. 6.5.5 West-Ward Pharms Recent Developments
  31. 6.6 US Pharm Holdings
  32. 6.6.1 US Pharm Holdings Company Information
  33. 6.6.2 US Pharm Holdings Business Overview
  34. 6.6.3 US Pharm Holdings Furosemide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 US Pharm Holdings Furosemide Product Portfolio
  36. 6.6.5 US Pharm Holdings Recent Developments
  37. 6.7 Ivax Sub Teva Pharms
  38. 6.7.1 Ivax Sub Teva Pharms Company Information
  39. 6.7.2 Ivax Sub Teva Pharms Business Overview
  40. 6.7.3 Ivax Sub Teva Pharms Furosemide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ivax Sub Teva Pharms Furosemide Product Portfolio
  42. 6.7.5 Ivax Sub Teva Pharms Recent Developments
  43. 6.8 Hospira
  44. 6.8.1 Hospira Company Information
  45. 6.8.2 Hospira Business Overview
  46. 6.8.3 Hospira Furosemide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hospira Furosemide Product Portfolio
  48. 6.8.5 Hospira Recent Developments
  49. 6.9 Emcure Pharms
  50. 6.9.1 Emcure Pharms Company Information
  51. 6.9.2 Emcure Pharms Business Overview
  52. 6.9.3 Emcure Pharms Furosemide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Emcure Pharms Furosemide Product Portfolio
  54. 6.9.5 Emcure Pharms Recent Developments
7 North America by Country
  1. 7.1 North America Furosemide Sales by Country
  2. 7.1.1 North America Furosemide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Furosemide Sales by Country (2021-2026)
  4. 7.1.3 North America Furosemide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Furosemide Market Size by Country
  6. 7.2.1 North America Furosemide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Furosemide Market Size by Country (2021-2026)
  8. 7.2.3 North America Furosemide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Furosemide Sales by Country
  2. 8.1.1 Europe Furosemide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Furosemide Sales by Country (2021-2026)
  4. 8.1.3 Europe Furosemide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Furosemide Market Size by Country
  6. 8.2.1 Europe Furosemide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Furosemide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Furosemide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Furosemide Sales by Country
  2. 9.1.1 Asia-Pacific Furosemide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Furosemide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Furosemide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Furosemide Market Size by Country
  6. 9.2.1 Asia-Pacific Furosemide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Furosemide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Furosemide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Furosemide Sales by Country
  2. 10.1.1 South America Furosemide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Furosemide Sales by Country (2021-2026)
  4. 10.1.3 South America Furosemide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Furosemide Market Size by Country
  6. 10.2.1 South America Furosemide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Furosemide Market Size by Country (2021-2026)
  8. 10.2.3 South America Furosemide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Furosemide Sales by Country
  2. 11.1.1 Middle East and Africa Furosemide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Furosemide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Furosemide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Furosemide Market Size by Country
  6. 11.2.1 Middle East and Africa Furosemide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Furosemide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Furosemide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Furosemide Value Chain Analysis
  2. 12.1.1 Furosemide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Furosemide Production Mode & Process
  7. 12.2 Furosemide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Furosemide Distributors
  10. 12.2.3 Furosemide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst